Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

Summary

This study is an early exploration clinical study with one arm. The study consists of two stages, namely the dose escalation stage and the dose extension stage:

Timeline

Start

2022-11-01

Primary completion

2025-12-30

Completion

2025-12-30

Outcome

Outcome not reported

Stopped (Business): “The study was terminated from a business perspective.”

Drugs

Indications